Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

New early marker in Parkinson’s disease

Published on: 29/01/2014 Reading time: 1 min
Le complexe coeruleus/subcoeruleus est visible dans cette nouvelle sequence IRM. Cela nous a permis d’étudier la relation entre cette petite structure (en blanc dans l’image) et le tonus musculaire pendant le sommeil paradoxal.
Retour à la recherche

A paper published in the prestigious journal Brain by a team of the Institut du Cerveau - ICM institute link rapid eye movement sleep disorders and Parkinson’s disease. These results open the possibilities to early diagnose development of the Parkinson’s disease.

Parkinson disease is a progressive degenerative neurological disorder affecting 150 000 persons in France. It is characterized by the death of a neuronal population producing dopamine, a neurotransmitter, chemical messenger allowing transmission of informations between neurons. The diminution of the concentration of dopamine is the source of the development of the disease. Indeed, symptoms arise when 60-80% of these specific neurons disappear.

These last few years, researchers studied non-dopaminergic symptoms and more notably rapid eye movement sleep behavior disorder affecting 30 to 60% of patients. Rapid eye movement sleep is traditionally characterized by dreams and is associated with a strong neuronal activity, ocular movements and diminution of muscle tone. Some patients with Parkinson disease have rapid eye movement sleep behavior disorders with increased muscular tone which could lead to nocturnal violence. Rapid eye movement sleep behavior disorders could arise in any healthy subject whithout neurological disease. However, these persons present a higher risk to develop Parkinson disease or demencia. Daniel GarcÍa-Lorenzo in the team of Marie Vidailhet et Stéphane Lehéricy just highlighted the role of a part of the brain named the coeruleus/subcoeruleus complex in the blocking of muscle tone during eye rapid movement sleep.

The team studied the integrity of this complex in patients with Parkinson’s disease using imaging approaches. They showed that patients with Parkinson’s disease have a reduced neuronal activity in the coeruleus/subcoeruleus complex associated with rapid eye movement sleep behavior disorder. Imaging datas combined with careful clinical evaluation as well as nocturnal video monitoring may be used as an early marker of non-dopaminergic Parkison’s disease pathology to predict the occurrence of Parkinson’s disease.

Le complexe coeruleus/subcoeruleus est visible dans cette nouvelle sequence IRM. Cela nous a permis d’étudier la relation entre cette petite structure (en blanc dans l’image) et le tonus musculaire pendant le sommeil paradoxal.
The coeruleus/subcoeruleus complex is visible in this new MRI sequence. This allowed us to study the relation between these small structures (in white on the image) and the muscle tone during rapid eye movement sleep.

Sources

Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, Lobo PP, Poupon C, Benali H, Arnulf I, et al.: The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain 2013, 136:2120-2129.

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news